Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China  

作　　者：Qu Simeng Wang Shuling 

机构地区：[1]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China

出　　处：《Asian Journal of Social Pharmacy》2024年第1期81-88,共8页亚洲社会药学（英文）

基　　金：2021 General Scientific Research Project of Liaoning Provincial Department of Education(No.LJKR0298);Liaoning Provincial Social Science Planning Fund Office(2019)(No.L19BGL034).

摘　　要：Objective To study the profit model of Chinese pharmaceutical O2O enterprises.Methods A case study of three typical pharmaceutical O2O enterprises was conducted,and their profit models were compared.Results and Conclusion The pharmaceutical O2O enterprises in China are divided into three categories according to the profit models.It is found that the current pharmaceutical O2O enterprises have problems such as simple profit model and low corporate profits.Based on these problems,it is recommended that relevant enterprises develop various business models to increase profit channels.Besides,they should establish and improve internal cost control systems.

关 键 词：pharmaceutical O2O profit model case analysis 

分 类 号：F426.7[经济管理—产业经济]